Medtronic continues to strengthen its position in cardiac ablation, building on a legacy of innovation in electrophysiology ...

Disc Medicine (IRON) posted strong APOLLO Phase 3 bitopertin results in EPP/XLP and plans an end-2026 NDA resubmission.

Disc Medicine reported that its pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic protoporphyria and X linked ...

Disc Medicine Inc. IRON on Monday reported positive topline results from its APOLLO Phase 3 trial evaluating bitopertin for ...

Disc Medicine, Inc. (NASDAQ:IRON) shares increased 60% after the biotechnology company reported positive topline results from ...

Disc Medicine said on Monday its experimental pill for a rare disease that causes ​extreme pain from sunlight met all of ‌its main and secondary goals in a late-stage trial, sending its shares surging ...

Disc Medicine’s bitopertin—rejected by the FDA in February—significantly reduced levels of a key disease biomarker and ...

Disc Medicine (IRON) shares jumped 32% in premarket trading on Monday ahead of topline results from its Phase 3 APOLLO trial ...

PGA Tour winner Will Zalatoris expects to miss 2027 after a planned November spinal fusion, his third major back procedure.

Member bios can be found here on LifeMine’s website.

With this approval, pro disc® C Nova joins pro disc C Vivo and pro disc C SK as three distinct pro disc cervical TDR devices ...

HeartTone Medical (02291.HK) announced that its wholly owned subsidiary, Shanghai Shape Memory Alloy Materials Co., Ltd., has obtained ...